T1	PrimaryOutcome 529 543	IMV- free days
T2	TimeFrame 544 554	in 28 days
R1	MeasuredAt Arg1:T1 Arg2:T2	
T3	SecondaryOutcome 601 610	mortality
T4	SecondaryOutcome 612 627	organ functions
T5	SecondaryOutcome 632 795	inflammatory parameters, including white blood cell counts, neutrophil counts, lymphocyte counts, procalcitonin, interleukin-6 (IL-6), and C-reactive protein (CRP)
T6	SecondaryOutcome 866 882	vasopressor days
T7	SecondaryOutcome 884 908	respiratory support days
T8	SecondaryOutcome 910 957	invasive mechanical ventilation (IMV)-free days
T9	SecondaryOutcome 959 993	patient condition improvement rate
T10	SecondaryOutcome 995 1031	patient condition deterioration rate
T11	SecondaryOutcome 1033 1064	length of ICU and hospital stay
T12	SecondaryOutcome 1066 1095	ICU and in-hospital mortality
T13	OutcomeDefinition 1195 1233	number of days a patient was extubated
R2	DefinedAs Arg1:T8 Arg2:T13	
T14	OutcomeDefinition 1367 1483	defined as the patient requiring HFNC or NIV on day 1 and requiring ECMO or IMV, or dying, after 7 days of treatment
R3	DefinedAs Arg1:T10 Arg2:T14	
T15	OutcomeDefinition 1528 1662	defined as the patient requiring ECMO or IMV on day 1 and switching to HFNC, NIV, or discharged from the ICU after 7 days of treatment
R4	DefinedAs Arg1:T9 Arg2:T15	
T16	TimeFrame 594 600	28-day
R5	MeasuredAt Arg1:T3 Arg2:T16	
T17	TimeFrame 1234 1261	after recruitment to day 28
R6	MeasuredAt Arg1:T8 Arg2:T17	
